Innovation1 Biotech Inc.
OTC: IVBT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Francis Knuettel
- Employees
- 1
- Headquarters
- Somerville, United States
- IPO year
- 2017
- Market cap
- $4.5K
- Website
- https://www.innovation1bio.com
Loading IVBT…
Loading profile data…Frequently asked questions about IVBT
What does Innovation1 Biotech Inc. (IVBT) do?
Innovation1 Biotech Inc. functions as a drug discovery enterprise, primarily engaged in creating modified botanical Schedule 1 molecules for use within the United States. The firm's pipeline encompasses five entirely synthetic, proprietary prodrugs that are currently in preclinical development, each designed to tackle a unique set of medical con...
Where does IVBT trade?
Innovation1 Biotech Inc. (IVBT) trades on the Other OTC.
What sector is IVBT in?
Innovation1 Biotech Inc. (IVBT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Innovation1 Biotech Inc.?
Francis Knuettel is the chief executive officer of Innovation1 Biotech Inc. (IVBT).
Where is Innovation1 Biotech Inc. headquartered?
Innovation1 Biotech Inc. is headquartered in United States.
Does IVBT pay a dividend?
Innovation1 Biotech Inc. (IVBT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did IVBT go public?
Innovation1 Biotech Inc. (IVBT) completed its initial public offering in 2017.